New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon?-Reference-Cited by-同舟云学术

New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon?

Published:2015-04-19 Issue:6 Volume:17 Page:
ISSN:1522-6417
Container-title:Current Hypertension Reports
language:en
Short-container-title:Curr Hypertens Rep

Author:

Paulis Ludovit,Rajkovicova Romana,Simko Fedor

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11906-015-0557-x.pdf

Reference116 articles.

1. Mancia G, Fagard R, Narkiewicz K, et al. ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.

2. Redon J, Olsen MH, Cooper RS, et al. Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J. 2011;32:1424–31.

3. The Pharmaceutical Research and Manufacturers of America (PhRMA). 2013 Report: Medicines in Development for Heart Disease and Stroke. In: Medicines in Development. PhRMA., 2015. http://www.phrma.org/sites/default/files/pdf/Heart_2013.pdf . Accessed 1 Mar 2015.

4. CenterWatch. FDA Approved Drugs for Cardiology/Vascular Diseases. In: FDA Approved Drugs by Therapeutic Area. CenterWatch. 2015. http://www.centerwatch.com/drug-information/fda-approvals/drug-areas.aspx?AreaID=1 . Accessed 1 Mar 2015.

5. Paulis L, Unger T. Novel therapeutic targets for hypertension. Nat Rev Cardiol. 2010;7:431–41.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed;Frontiers in Cardiovascular Medicine;2023-12-21

2. Neuroimmune Interactions in the Lung;Annual Review of Immunology;2023-11-21

3. Theoretical investigation on known renin inhibitors and generation of ligand-based pharmacophore models for hypertension treatment;Journal of Biomolecular Structure and Dynamics;2023-10-28

4. Renin–angiotensin–aldosterone system inhibitors. New and old approaches;Angiotensin;2023

5. Nanoemulsions for the Delivery of Anti-Hypertensive Drugs;Handbook of Research on Nanoemulsion Applications in Agriculture, Food, Health, and Biomedical Sciences;2022